Skip to main content
Elbit Imaging-M Ltd. logo

Elbit Imaging-M Ltd. — Investor Relations & Filings

Ticker · EMITF-M ISIN · US2842771006 LEI · 549300UWRB10FFBCZQ53 TA Real estate activities
Open in API
Filings indexed 2,641 across all filing types
Latest filing 2018-12-06 Report Publication Anno…
Country IL Israel
Listing TA EMITF-M

About Elbit Imaging-M Ltd.

http://www.elbitimaging.com/

Elbit Imaging Ltd. is a holding company with investments and activities primarily focused on two sectors: real estate and medical industries. The company's real estate portfolio involves the development, operation, and management of commercial properties such as shopping centers, entertainment venues, and hotels. In the medical sector, its activities include the research, development, production, and marketing of advanced medical devices. A key area of focus is magnetic resonance imaging (MRI)-guided focused ultrasound treatment systems.

Recent filings

Filing Released Lang Actions
Immediate Report
Report Publication Announcement Classification · 98% confidence The document is a short filing (2359 chars) submitted to the Israel Securities Authority and the Tel Aviv Stock Exchange. It explicitly states, "Attached hereto is a report on *ELBIT IMAGING LTD* *Elbit_Imaging_-_PR_BuyBack_isa.pdf*". This structure—a brief announcement referencing an attached PDF report—fits the definition of a Report Publication Announcement (RPA) according to the 'MENU VS MEAL' rule. The content suggests the attached PDF relates to a 'BuyBack', which often falls under capital changes or share transactions, but the primary function of *this* document is announcing the publication of the main report.
2018-12-06 English
Immediate Report
Regulatory Filings Classification · 95% confidence The document is a short press release from Elbit Imaging Ltd. dated December 4, 2018, announcing an update regarding the term sheet for the sale of a plot of land in Chennai, India. Specifically, it details an extension of the closing date and a change in the advance deposit structure to an interest calculation. This type of announcement, which relates to a specific corporate transaction (sale of an asset), does not fit neatly into standard periodic reports (10-K, IR, ER) or common corporate actions (DIV, SHA, MANG). Since it is a specific, material corporate event update that doesn't match the other specific categories (like Director's Dealing, Capital Change, or Dividend Notice), the most appropriate classification is the general 'Regulatory Filings' fallback category (RNS), as it is a material announcement made to the market.
2018-12-04 English
Immediate Report
Report Publication Announcement Classification · 98% confidence The document is very short (2344 characters) and explicitly states, "Attached hereto is a report on *ELBIT IMAGING LTD* *Chennai_isa.pdf*". This structure—a brief announcement referencing an attached or linked document—fits the definition of a Report Publication Announcement (RPA) according to Rule 2 ('THE "MENU VS MEAL" RULE'). It is not the full report itself (like 10-K or IR). The filing is made to the Israel Securities Authority and Tel Aviv Stock Exchange, but the content is an announcement of publication, not the content of the underlying report.
2018-12-04 English
Immediate Report
Regulatory Filings Classification · 93% confidence The document is a press release from Elbit Imaging announcing updated findings from a clinical study conducted by Gamida Cell (an indirect holding). The content focuses on scientific data updates from a Phase I/II study presented at a medical conference (ASH 2018) and provides an outlook on a future Phase 3 study enrollment. This type of announcement, detailing specific operational or clinical progress without being a full financial report (10-K, IR) or a general earnings release (ER), fits best under the general category for regulatory or operational announcements that are not covered by more specific codes like DIRS, DIV, or CAP. Since it is an announcement of clinical trial data, it is not a standard financial filing. Given the options, it is a specific operational update. It is not a Call Transcript (CT), Earnings Release (ER), or Interim Report (IR). It is most closely related to general operational news. If it were a formal legal filing detailing the study results, it might fit LTR, but as a press release summarizing positive data, it functions as a general corporate update. In the absence of a specific 'Clinical Trial Update' code, and given that it is a press release detailing operational progress, it falls under the broad 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory/operational announcements not covered elsewhere. However, since it is a detailed update on a specific business segment's progress, it is not merely a 'Report Publication Announcement' (RPA). I will classify it as RNS as the best fit for a non-financial, non-management, non-legal, non-dividend specific corporate announcement.
2018-12-03 English
Immediate Report
Report Publication Announcement Classification · 98% confidence The document is very short (2342 characters) and explicitly states, "Attached hereto is a report on*ELBIT IMAGING LTD* *588v1_isa.pdf*". This structure, which announces the publication of an attached or linked report rather than containing the full report content itself, strongly indicates a Report Publication Announcement (RPA). It is not a full financial report (like 10-K or IR) or a specific type of announcement like Director's Dealing or Dividend Notice. The presence of the ISA and TASE headers suggests it is a regulatory filing, but the primary action described is the publication of another document.
2018-12-03 English
Immediate Report
Share Issue/Capital Change Classification · 95% confidence The document is a press release from Elbit Imaging Ltd. announcing the completion of a share sale transaction under a Share Purchase Agreement (SPA) with Exigent Capital Group. The core subject is the aggregate sale of a significant block of shares (60,087,537 Elbit Medical shares) and the expiration of the agreement. This transaction involves a change in ownership/holding structure related to the company's assets/investments, but it is not a standard financing event (CAP), a director's trade (DIRS), or a general capital change announcement (SHA). It is a specific corporate transaction announcement. Given the options, this type of announcement regarding a major transaction or change in shareholding structure, especially one involving a specific agreement and its conclusion, fits best under 'Major Shareholding Notification' (MRQ) as it details a significant change in the percentage of shares held by an external party, or potentially 'Regulatory Filings' (RNS) if it were a mandatory disclosure not covered elsewhere. However, since it details the final result of a share purchase agreement leading to a specific holding percentage (26% sold, 63% remaining), MRQ, which covers changes in significant share ownership levels, is the most appropriate fit among the specific codes, even though it's a sale *by* the company rather than an acquisition *by* a third party crossing a threshold. Given the context of corporate actions, it is a specific transaction disclosure. If it were a general announcement of a transaction, TAR (M&A) might apply, but this is a specific share sale. Since it details the final outcome of a share transaction affecting ownership structure, MRQ is the closest fit for significant ownership changes.
2018-11-29 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.